Alzheimer's Disease Therapy

Comprehensive Alzheimer's Disease Therapy Management

Soleo Health has been selected as a specialty pharmacy partner for ADUHELM™ (aducanumab-avwa). ADUHELM recently received accelerated approval from the U.S. Food & Drug Administration (FDA) for the treatment of Alzheimer’s disease. Soleo Health will distribute ADUHELM directly to providers and prescribers for patient administration throughout the United States. ADUHELM is the first Alzheimer’s drug to be FDA-approved for treatment in nearly 20 years.

Patients receiving ADUHELM will be supported through our Alzheimer’s Disease Therapeutic Care Management Center (TCMC). Our dedicated Alzheimer’s TCMC is staffed with specially trained interdisciplinary teams comprising highly experienced therapy-care pharmacists, registered nurses, and reimbursement and patient care specialists. Our Alzheimer’s TCMC will be supported by our specialty pharmacies located nationwide with pharmacy licensure in all 50 states.

For patients receiving this new therapy, Soleo Health offers personalized customer service to provider offices and exceptional care for patients receiving ADUHELM in one of Soleo’s ambulatory infusion centers, where available.

Access to Care
Soleo Health is committed to assisting patients gain access to approved intravenous Alzheimer's disease therapy. Our dedicated intake and reimbursement specialists provide coordination between patients and their healthcare provider to initiate care. Our team is available to answer questions regarding treatment and side effect management and provide patient and caregiver education.

Enhancing Our Patient Experience
We know patients have a choice in healthcare providers. Soleo Health is dedicated to enhancing our patients' experience. In fact, Soleo Health has a 98% patient satisfaction rate and 99% of our patients would refer us to a friend or family.

The Soleo Health Difference

  • Dedicated Alzheimer’s Therapeutic Care Management Center with 24/7 access to clinical pharmacists and registered nurses
  • Timely insurance benefit verification, authorization and start of care
  • Individualized patient care plans and Alzheimer’s disease-specific patient assessments through SoleMetrics®
  • Patient advocacy including comprehensive patient and caregiver education and support
  • Soleo Connect® patient and prescriber mobile engagement platform

We are dedicated to enhancing our patients’ experience through innovative and cost effective solutions resulting in an exceptional patient experience.

To learn more about Soleo's Alzheimer's disease program, contact our Alzheimer’s Disease Therapeutic Care Management Center at or call us at 844.960.9090.